Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing Capabilities
State-of-the-art facility will expand capacity for producing tissue-based and additional regenerative medicines CAMBRIDGE, Mass. and…
State-of-the-art facility will expand capacity for producing tissue-based and additional regenerative medicines CAMBRIDGE, Mass. and…
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Clinical Data from one research site for GCC19CART, ICT’s lead solid tumor program, for 3rd…
Topline data expected to be presented at a scientific conference in May 2022 Independent data…
BOTHELL, Wash., April 21, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…
Impel Celebrates Its One-Year Anniversary as a Public Company SEATTLE, April 21, 2022 (GLOBE NEWSWIRE)…
Mr. Zergebel brings over 20 years of industry experience, primarily focused in oncology, and broad…
Tien V. Le, M.D., recently performed the first procedure integrating the Remi Robotic Navigation System,…
Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and…
seqWell raises $7M Series C funding, led by Codexis Current investors Research Corporation Technologies and…
WARMINSTER, Pa., April 21, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
PORTLAND, Ore., April 21, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)…
Expands rare cannabinoid portfolio beyond current CBC and CBT Releases White Paper outlining research into…
Overall response rate (ORR) of 43% and median duration of response of 6 months seen…
Arena Pharmaceuticals and Actelion veteran brings deep industry experience as VectivBio prepares for key upcoming catalysts…
Nearly seven in ten GA patients believe the impact on their independence and quality of…
RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
DEVON, Pa., April 21, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
HAIFA, Israel, April 21, 2022 – MeMed (or “the Company”), a leader in the emerging…
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…